健康成人循环GDF8/GDF11及其拮抗剂与年龄和骨骼肌力量的关系
该研究用液相色谱-串联质谱法测量160名22-93岁健康成人血浆GDF8、GDF11及其拮抗剂,发现GDF11及FST315、WFIKKN1、WFIKKN2随年龄变化,且FST315和WFIKKN1独立于年龄与膝关节力量负相关。
要点
- GDF11前结构域、成熟蛋白、FST315、WFIKKN2与年龄正相关,WFIKKN1与年龄负相关。
- FST315和WFIKKN1独立于年龄与膝关节力量负相关。
- GDF8和GDF11成熟蛋白本身与膝关节力量无独立关联。
核心结论
- 健康成人血浆GDF11及拮抗剂FST315、WFIKKN1、WFIKKN2随年龄变化,拮抗剂而非GDF8/GDF11本身独立与骨骼肌力量相关。
研究设计与样本
- 横断面研究,纳入160名22-93岁健康成人,用多重选择反应监测和液相色谱-串联质谱测血浆蛋白,用等速测力计测膝伸扭矩。
临床怎么用
- 监测血浆FST315和WFIKKN1可能有助于评估健康成人骨骼肌力量下降风险,但尚需进一步研究验证。
局限性
- 横断面设计不能推断因果关系;样本为健康成人,外推至衰虚弱或肌少症人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Growth and differentiation factors 8 (GDF8) and 11 (GDF11) have attracted attention as targets for rejuvenating interventions. The biological activity of these proteins may be affected by circulating antagonists such as their respective prodomains, follistatin (FST315), WFIKKN1, and WFIKKN2. Reports of the relationship of GDF8 and GDF11 and their antagonists with aging and aging phenotypes such as skeletal muscle strength have been conflicting possibly because of difficulties in measuring these proteins and polypeptides. METHODS: Plasma GDF8 and GDF11 and their antagonists were measured using a multiplexed selected reaction monitoring assay and liquid chromatography-tandem mass spectrometry in 160 healthy adults aged 22-93 years. Quadriceps strength was measured by knee extensor torque using isokinetic dynamometry. RESULTS: Spearman correlations with age were the following: GDF11 prodomain (r = .30, p = .001), GDF11 mature protein (r = .23, p = .004), FST315 (r = .32, p < .0001), WFIKKN1 (r = -.21, p = 0.008), and WFIKKN2 (r = .18, p = .02). Independent of age, FST315 and WFIKKN1 were negatively associated with knee strength (p = .02, p = .03, respectively) in a multivariable model that included both GDF8 and GDF11 mature proteins. CONCLUSIONS: When measured by an antibody-free selected reaction monitoring assay, GDF8, GDF11, and their antagonists are found in the circulation in the ng/mL range. In healthy adults, plasma GDF11 and antagonists FST315, WFIKKN1, and WFIKKN2 differed by age. Antagonists of GDF8 and GDF11, but not GDF8 and GDF11, were independently associated with skeletal muscle strength. Further work is needed to characterize the relationship of these protein and polypeptides with sarcopenia-related phenotypes such as physical function and walking disability.
引用
- Semba RD, Zhang P, Zhu M, et al. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30380014. doi:10.1093/gerona/gly255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。